IP Library Granted Patent US 11,871,767
Granted Patent B2
US 11,871,767 · App. 17/354,306 · Granted Jan 16, 2024

Microbial compositions and methods for ruminant health and performance

Inventors: Mallory Embree (San Diego, CA); Cameron Martino (San Diego, CA); Norman Pitt (San Diego, CA); Jordan Embree (San Diego, CA); Corey Dodge (Encinitas, CA)
Assignee: Native Microbials, Inc.
A23K10/18A23K50/10A61K35/74A61P1/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,871,767
App. No.
17/354,306
Granted
Jan 16, 2024
Kind
B2
Abstract

The disclosure relates to isolated microorganisms—including novel strains of the microorganisms—microbial ensembles, and compositions comprising the same. Furthermore, the disclosure teaches methods of utilizing the described microorganisms, microbial compositions, and compositions comprising the same, in methods for modulating the agricultural production of ruminants. In particular aspects, the disclosure provides methods of increasing feed efficiency, and methods of decreasing acidosis.

Claims (30)

1. A method for improving one or more desirable traits in a ruminant, the method comprising administering to the ruminant an effective amount of a microbial composition comprising:

(a) a purified population of bacteria comprising a 16S nucleic acid sequence that shares at least 97% sequence identity to SEQ ID NO: 75; and

(b) a carrier suitable for ruminant administration.

2. The method of claim 1 , wherein the microbial composition further comprises a purified population of one or more bacteria sharing at least 97% sequence identity to a 16S nucleic acid sequence selected from: SEQ ID NOs: 1-74 and 76-5993.

3. The method of claim 2 , wherein the purified population of one or more bacteria comprises: a bacterium comprising a 16S nucleic acid sequence that shares at least 97% sequence identity to SEQ ID NO: 17; and/or a bacterium comprising a 16S nucleic acid sequence that shares at least 97% sequence identity to SEQ ID NO: 86.

4. The method of claim 2 , wherein the purified population of one or more bacteria comprises: a bacterium comprising a 16S nucleic acid sequence that shares at least 98% sequence identity to SEQ ID NO: 17; and/or a bacterium comprising a 16S nucleic acid sequence that shares at least 98% sequence identity to SEQ ID NO: 86.

5. The method of claim 2 , wherein the purified population of one or more bacteria comprises: a bacterium comprising a 16S nucleic acid sequence of SEQ ID NO: 5457; a bacterium comprising a 16S nucleic acid sequence of SEQ ID NO: 5644; and/or a bacterium comprising a 16S nucleic acid sequence of SEQ ID NO: 5709.

6. The method of claim 2 , wherein the purified population of one or more bacteria comprises: a bacterium comprising a 16S nucleic acid sequence of SEQ ID NO: 5457; a bacterium comprising a 16S nucleic acid sequence of SEQ ID NO: 5644; and a bacterium comprising a 16S nucleic acid sequence of SEQ ID NO: 5709.

7. The method of claim 2 , wherein the purified population of one or more bacteria comprises: a bacterium comprising a 16S nucleic acid sequence of SEQ ID NO: 5457; and a bacterium comprising a 16S nucleic acid sequence of SEQ ID NO: 5644.

8. The method of claim 2 , wherein the purified population of one or more bacteria comprises: a bacterium comprising a 16S nucleic acid sequence of SEQ ID NO: 5457; and a bacterium comprising a 16S nucleic acid sequence of SEQ ID NO: 5709.

9. The method of claim 2 , wherein the purified population of one or more bacteria comprises: a bacterium comprising a 16S nucleic acid sequence of SEQ ID NO: 5644; and a bacterium comprising a 16S nucleic acid sequence of SEQ ID NO: 5709.

10. The method of claim 2 , wherein the purified population of one or more bacteria comprises: a bacterium comprising a 16S nucleic acid sequence of SEQ ID NO: 5457.

11. The method of claim 2 , wherein the purified population of one or more bacteria comprises: a bacterium comprising a 16S nucleic acid sequence of SEQ ID NO: 5644.

12. The method of claim 2 , wherein the purified population of one or more bacteria comprises: a bacterium comprising a 16S nucleic acid sequence of SEQ ID NO: 5709.

13. The method of claim 2 , wherein the purified population of one or more bacteria comprises: a bacterium deposited as B-67553; a bacterium deposited as B-67550; and/or a bacterium deposited as B-67552.

14. The method of claim 2 , wherein the one or more bacteria are in the form of spores.

15. The method of claim 1 , wherein the microbial composition further comprises a purified population of one or more bacteria sharing at least 97% sequence identity to a 16S nucleic acid sequence selected from: SEQ ID NOs:1-74, 76-136, 5369-5378, 5398, 5425, 5450, 5460, 5462, 5473, 5474, 5483, 5502, 5511, 5517, 5519, 5526, 5576, 5582, 5589, 5598, 5614, 5619, 5621, 5627, 5629, 5631, 5663, 5670, 5726, 5746, 5757, 5764, 5777, 5797, 5802, 5868, 5872, 5930, 5947, 5949, 5955, 5956, 5971, 5973, 5977, 5989, and 5991.

16. The method of claim 1 , wherein the microbial composition is a tablet, a capsule, a pill, a feed additive, a powder, a food ingredient, a food preparation, a food supplement, a water additive, a thermostable-additive, a moisture-resistant additive, a pre-pelleted feed additive, a pelleted feed additive, a post-pelleting-applied feed additive, a consumable solution, a consumable spray additive, a consumable solid, a consumable gel, an injection, a suppository, a drench, a bolus, or combinations thereof.

17. The method of claim 1 , wherein the bacteria are encapsulated.

18. The method of claim 17 , wherein the bacteria are encapsulated in one or more of a polymer, carbohydrate, sugar, sugar alcohol, surfactant, plastic, glass, polysaccharide, lipid, wax, oil, fatty acid, amino acid, or glyceride.

19. The method of claim 1 , wherein the bacteria comprise at least 10 2 cells.

20. The method of claim 1 , wherein the microbial composition is stable under ambient conditions for at least one week.

21. The method of claim 1 , wherein the microbial composition is orally administered to the ruminant.

22. The method of claim 21 , wherein the microbial composition is fed to the ruminant.

23. The method of claim 22 , wherein the ruminant is fed a step-up diet or a finishing diet comprising the microbial composition.

24. The method of claim 1 , wherein the ruminant administered the effective amount of the microbial composition exhibits a shift in the microbiome of the rumen.

25. The method of claim 1 , wherein the one or more desirable traits are selected from the group consisting of: a decrease in the incidence and/or prevalence of acidosis or bloat, a decrease in the amount of carbon dioxide and/or carbonic acid in the rumen, an increase in the amount of meat marbling, an increase in feed efficiency, an increase in feed utilization, an increase in feed digestibility, a decrease in manure production, an increase in performance, an increase in weight, an increase in musculature, a decrease in nitrous oxide production and emission, a decrease in methane production and emission, improved gastrointestinal health, and a decrease in mortality.

26. The method of claim 25 , wherein the one or more desirable traits is an increase in performance.

27. The method of claim 25 , wherein the one or more desirable traits is an increase in feed efficiency.

28. The method of claim 25 , wherein the one or more desirable traits is a decrease in the incidence and/or prevalence of acidosis or bloat in the ruminant.

Assignments (3)
SECURITY INTEREST Recorded Jul 30, 2025
From: NATIVE MICROBIALS, INC.
To: WESTERN ALLIANCE BANK
Reel/Frame 072324/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2021
From: EMBREE, MALLORY; MARTINO, CAMERON; PITT, NORMAN; EMBREE, JORDAN; DODGE, COREY
To: ASCUS BIOSCIENCES, INC.
Reel/Frame 056700/0635 →
CHANGE OF NAME Recorded Jun 29, 2021
From: ASCUS BIOSCIENCES, INC.
To: NATIVE MICROBIALS, INC.
Reel/Frame 056770/0723 →
Continuity (4)
Continuation 15965661 · Apr 27, 2018
Provisional Application 62578188 · Oct 27, 2017
Provisional Application 62491845 · Apr 28, 2017
Related Publication 20220386646A1 · Dec 8, 2022